DUSP23 (NM_017823) Human 3' UTR Clone
CAT#: SC202870
3' UTR clone of dual specificity phosphatase 23 (DUSP23) for miRNA target validation
Need custom modification / cloning service?
Get a free quote
CN¥ 4,845.00
货期*
3周
规格
Product images

经常一起买 (2)
Specifications
Product Data | |
Product Name | DUSP23 (NM_017823) Human 3' UTR Clone |
Vector | pMirTarget |
Synonyms | DUSP25; LDP-3; LDP3; MOSP; VHZ |
ACCN | NM_017823 |
Insert Size | 235 bp |
Sequence Data |
>SC202870 3’UTR clone of NM_017823
The sequence shown below is from the reference sequence of NM_017823. The complete sequence of this clone may contain minor differences, such as SNPs. Blue=Stop Codon Red=Cloning site GGCAAGTTGGACGCCCGCAAGATCCGCGAGATTCTCATTAAGGCCAAGAAGGGCGGAAAGATCGCCGTG TAACAATTGGCAGAGCTCAGAATTCAAGCGATCGCC GTCTTCCAGTTCTACCAGCGAACGAAATAAGGGGCCTTAGTACCCTTCTACCAGGCCCTCACTCCCCTT CCCCATGTTGTCGATGGGGCCAGAGATGAAGGGAAGTGGACTAAAGTATTAAACCCTCTAGCTCCCATT GGCTGAAGACACTGAAGTAGCCCACCCCTGCAGGCAGGTCCTGATTGAAGGGGAGGCTTGTACTGCTTT GTTGAATAAATGAGTTTTACGAACCAGG ACGCGTAAGCGGCCGCGGCATCTAGATTCGAAGAAAATGACCGACCAAGCGACGCCCAACCTGCCATCA CGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGG |
Restriction Sites | SgfI-MluI |
OTI Disclaimer | Our molecular clone sequence data has been matched to the sequence identifier above as a point of reference. Note that the complete sequence of this clone is largely the same as the reference sequence but may contain minor differences , e.g., single nucleotide polymorphisms (SNPs). |
Reference Data | |
RefSeq | NM_017823.5 |
Synonyms | DUSP25; LDP-3; LDP3; MOSP; VHZ |
Summary | Protein phosphatase that mediates dephosphorylation of proteins phosphorylated on Tyr and Ser/Thr residues. In vitro, it can dephosphorylate p44-ERK1 (MAPK3) but not p54 SAPK-beta (MAPK10) in vitro. Able to enhance activation of JNK and p38 (MAPK14).[UniProtKB/Swiss-Prot Function] |
Locus ID | 54935 |
MW | 8.7 |
Documents
Product Manuals |
FAQs |
Resources
Customer
Reviews
Loading...